Lifeward Ltd. 8-K

What Happened Lifeward Ltd. announced that it has restored compliance with Nasdaq Listing Rule 5605(c)(2)(A) after appointing three members to its Audit Committee. The company previously received a Nasdaq notice that it was non‑compliant following the resignation of director Hadar Levy. On March 30, 2026, Nasdaq’s Listing Qualifications Staff acknowledged the appointments and confirmed the matter is closed.

Key Details

• Resignation causing non‑compliance: Hadar Levy resigned from the Board and Audit Committee, triggering Nasdaq’s notice.
• New appointees: Messrs. Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick were appointed to the Audit Committee.
• Nasdaq rule cited: Rule 5605(c)(2)(A) requires an audit committee of at least three members.
• Timing/cure period: Nasdaq had given a cure period until the earlier of the company’s next annual meeting or February 24, 2027 (with an August 24, 2026 evidencing deadline if the next annual meeting is held before August 24, 2026).

Why It Matters Restoring an appropriately staffed audit committee resolves a listing‑rule compliance issue and reduces the risk of further regulatory escalation, including potential delisting procedures. For investors, this preserves governance oversight of financial reporting and maintains the company’s standing on the Nasdaq exchange.